Effectiveness and Safety of the Colonoscopy With "Visualization" Balloon

Colonic Adenomatous Polyps Clinical Trial

Official title:

A Randomized Controlled Trial to Evaluate Effectiveness and Safety of the Colonoscopy With the "Visualization" Balloon

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02117232
• Other study ID #: VB-001
• Status: Completed
• Phase: N/A
• Start date: March 2014
• Est. completion date: December 2017

Study information

• Verified date: August 2018
• Source: Mercy Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Colonoscopy has become the "gold standard" in detection of colonic polyps and colon cancer. However, colonoscopy causes significant abdominal discomfort and abdominal pain during and after the procedure, requiring intravenous sedation and use of analgesics. The discomfort and pain are mostly caused by air insufflation and intubation difficulties during advancement of the colonoscope in order the reach the cecum.

Study Hypothesis: Use of the "Visualization" Balloon will facilitate advancement of the colonoscope and will eliminate the need for colonic distention with the air or CO2, which can shortened the length of the procedure, reduce patient's discomfort and can decrease amount of sedatives and analgesics used during colonoscopy.

Description:

The goal of this study is to evaluate effectiveness and safety of a "Visualization" Balloon for performance of colonoscopy.

Our hypothesis is that, use of "Visualization" Balloon will decrease colonic distention, patient's discomfort, use of sedatives and analgetics during procedure and will simplify the performance of colonoscopy resulting in shortening of procedure time and increasing the rate of cecal intubation.

Specific aims of the study:

1. To compare procedure time and effectiveness of the "Visualization" Balloon colonoscopy with traditional CO2-insufflation colonoscopy.

2. To compare safety profiles between traditional CO2-insufflation colonoscopy and colonoscopy using the "Visualization" Balloon.

4 STUDY ENDPOINTS 4.1 Primary Outcome To compare the mean cecal intubation time achieved with "Visualization" Balloon colonoscopy, with the mean cecal intubation time achieved with standard colonoscopy using CO2 insufflation.

4.2 Secondary Outcomes

To compare "Visualization" Balloon colonoscopy with standard CO2-insufflation colonoscopy in regards of:

1. Total amount of carbon dioxide (CO2) gas for colonic insufflation used during the procedure.

2. Ease of colonoscope insertion.

3. The length of the colonoscope when it reaches the cecum. 4 Colonoscope withdrawal time and total procedure time.

5. Cecal intubation rate. 6. Total dosage of analgesics and sedative during procedure. 7. Patient satisfaction: perceived pain and discomfort immediately after the procedure and in 24 hours post procedure.

8. Complications during and after colonoscopy. 9. Polyp detection rate.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 216
• Est. completion date: December 2017
• Est. primary completion date: December 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 17 Years to 90 Years

Eligibility

Inclusion Criteria:

1. The patient is undergoing colonoscopy for colo-rectal cancer screening, polypectomy or for diagnostic workup.

2. Subject is able to understand the risks and benefits of participating in the study and must be willing to sign and date the Informed Consent Form for this study approved by the Institutional Review Board (IRB.)

3. Age from 17 to 90 years.

4. Be willing and able to comply with the requirements of the protocol.

5. Be willing to refrain from participating in any other investigational interventional study while enrolled in this study.

6. Female subjects must have a negative pregnancy test within the last 24 hours timeline and have no intentions of becoming pregnant during participation in the study, or be sterilized.

Exclusion Criteria:

1. Subjects with a history of previous colonic resection.

2. Subjects with uncorrectable bleeding disorders (INR more than 1.5, platelet count less than 50,000).

3. Subjects unwilling or unable to give written consent to participate in the investigation or unable to comply with the requirements of the protocol.

4. Subjects with suspected colonic strictures potentially precluding complete colonoscopy.

5. Subjects who received any experimental drug or device within the previous three months.

6. Female subjects who were pregnant or lactating or were intending to become pregnant during the period of the study, or who would not use an adequate method of contraception (contraceptive pill, intra-uterine device) for the duration of the study.

7. Subjects who possessed any psychological condition, or were under treatment for any condition which, in the opinion of the Investigator and/or consulting physicians(s), would constitute an unwarranted risk.

Related Conditions & MeSH terms

• Adenomatous Polyps
• Colonic Adenomatous Polyps

Intervention

Device:
• Visualization balloon
The "Visualization" Balloon is a disposable medical device that is used during the advancement of the colonoscope inside the colon. The intended use of the "Visualization" Balloon is to help insertion of the colonoscope into the colon without the aid of gas (air or CO2) insufflation as with standard colonoscopy. The "Visualization" Balloon is inserted through the biopsy channel of the colonoscope prior to the colonoscope introduction into the rectum. The "Visualization" Balloon is an inflatable balloon that opens up the lumen of the gastrointestinal tract, thereby allowing the endoscopist to advance the endoscope inside and to view the gastrointestinal tract through the clear balloon.
• Traditional CO2 insufflation colonoscopy
Traditional colonoscopy performed with CO2 insufflation without "Visualization" balloon

Locations

Country	Name	City	State
United States	Mercy Medical Center	Baltimore	Maryland

Sponsors (1)

Lead Sponsor	Collaborator
Mercy Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Amount of carbon dioxide used	Total amount of carbon dioxide used during colonoscopy	Immediately
Primary	Cecal intubation time	Time required to reach cecum	Immediately
Secondary	Length of colonoscope when it reaches cecum	Total length of colonoscope when it reaches cecum	Immediately
Secondary	Ease of colonoscope insertion	Easy of colonoscope insertion to cecum	Immediate
Secondary	Dose of analgesics and sedatives used	Dose of analgesics and sedatives used during insertion and total dose for the entire procedure	Immediately
Secondary	Patient satisfaction	Patient satisfaction: perceived pain and discomfort immediately after the procedure and in 24 hours post procedure.	Immediately and in 24 hours
Secondary	Total procedure time	Total time required to complete colonoscopy	Immediately